Skip to main content
TipRanks
Go Ultimate75% OFF

Medicenna Therapeutics Corp (MDNAF) Ratios

251 Followers

Medicenna Therapeutics Corp Ratios

MDNAF's free cash flow for Q1 2027 was C$-4.43M. For the 2027 fiscal year, MDNAF's free cash flow was increased by C$0.00 and operating cash flow was C$-4.43M. See a summary of the company’s cash flow.

Financial ratios
RatiosMar 26Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio1.526.356.669.578.92
Quick Ratio1.526.356.669.578.92
Cash Ratio1.145.605.938.847.83
Solvency Ratio-3.07-1.27-1.830.22-8.63
Operating Cash Flow Ratio-3.28-3.72-5.68-3.33-9.00
Short-Term Operating Cash Flow Coverage0.000.000.000.000.00
Net Current Asset ValueC$ 2.35MC$ 18.88MC$ 5.13MC$ 29.43MC$ 20.77M
Leverage Ratios
Debt-to-Assets Ratio0.010.010.000.000.00
Debt-to-Equity Ratio0.050.010.000.000.00
Debt-to-Capital Ratio0.050.010.000.000.00
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio3.411.493.691.241.13
Debt Service Coverage Ratio0.000.000.000.00-327.65
Interest Coverage Ratio0.000.000.000.00-323.19
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.000.000.000.000.00
Net Debt to EBITDA0.261.900.912.060.91
Profitability Margins
Gross Profit Margin0.00%0.00%0.00%0.00%0.00%
EBIT Margin0.00%0.00%0.00%0.00%0.00%
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Profit Margin0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT93.44%90.60%100.00%-15.40%100.31%
EBT Per EBIT83.10%60.24%129.51%46.43%101.24%
Return on Assets (ROA)-217.75%-41.59%-133.09%4.24%-96.55%
Return on Equity (ROE)-741.70%-61.82%-490.58%5.25%-108.69%
Return on Capital Employed (ROCE)-793.24%-90.33%-120.85%-66.30%-107.03%
Return on Invested Capital (ROIC)-725.41%-81.67%-120.85%10.21%-107.03%
Return on Tangible Assets-218.97%-41.67%-133.49%4.25%-96.82%
Earnings Yield-34.58%-15.71%-20.20%2.72%-25.28%
Efficiency Ratios
Receivables Turnover0.000.000.000.000.00
Payables Turnover0.020.020.000.000.02
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.000.000.000.000.00
Asset Turnover0.000.000.000.000.00
Working Capital Turnover Ratio0.000.000.000.000.00
Cash Conversion Cycle-22980.78-17924.82-151110.00-118041.00-16060.00
Days of Sales Outstanding0.000.000.000.000.00
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding22980.7817924.82151110.00118041.0016060.00
Operating Cycle0.000.000.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-0.22-0.22-0.23-0.20-0.43
Free Cash Flow Per Share0.00-0.22-0.23-0.20-0.43
Dividend Paid and CapEx Coverage Ratio-1.00-499.760.000.000.00
Capital Expenditure Coverage Ratio-1.00-499.760.000.000.00
Operating Cash Flow Coverage Ratio-150.61-98.170.000.000.00
Operating Cash Flow to Sales Ratio0.000.000.000.000.00
Free Cash Flow Yield0.00%-21.99%-12.90%-22.22%-26.33%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-2.91-6.53-4.9536.82-3.96
Price-to-Sales (P/S) Ratio0.000.000.000.000.00
Price-to-Book (P/B) Ratio21.453.9324.281.934.30
Price-to-Free Cash Flow (P/FCF) Ratio0.00-4.55-7.75-4.50-3.80
Price-to-Operating Cash Flow Ratio-2.97-4.56-7.75-4.50-3.80
Price-to-Earnings Growth (PEG) Ratio-0.060.110.00-0.35-0.20
Enterprise Value Multiple-1.99-3.89-5.84-1.43-3.06
Enterprise Value47.11M50.47M109.06M23.37M69.04M
EV to EBITDA-1.99-3.89-5.84-1.43-3.06
EV to Sales0.000.000.000.000.00
EV to Free Cash Flow0.00-3.05-6.71-1.85-2.93
EV to Operating Cash Flow-2.63-3.06-6.71-1.85-2.93
Tangible Book Value Per Share0.030.250.070.450.38
Shareholders’ Equity Per Share0.030.250.070.460.38
Tax and Other Ratios
Effective Tax Rate0.070.090.001.15-0.00
Revenue Per Share0.000.000.000.000.00
Net Income Per Share-0.22-0.15-0.370.02-0.42
Tax Burden0.930.911.00-0.151.00
Interest Burden0.831.001.360.621.00
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.000.000.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality0.971.400.641.261.04

Currency in CAD